What is it about?
It is about the medications used to treat multiple sclerosis. The treatment of MS is challenging, and many drugs have evolved primarily for the last 20-30 years. From the introduction of interferons in 1993 until now, there are more than sixteen disease-modifying therapies (DMTs) approved. These drugs have different pharmacologic forms like injections, oral forms, and intravenous infusion drugs. Each one has its benefits and drawbacks. Moreover, like any other patient, MS patient has other symptoms that are not covered by DMT and need symptomatic treatment. In this chapter, we attempt to present medications used to treat acute relapse, different DMTs, symptomatic treatment for different MS symptoms, and besides, we give attention to drugs under clinical trials.
Featured Image
Photo by Robina Weermeijer on Unsplash
Why is it important?
Because multiple sclerosis is a common disease of the nervous system, affects young adults (20-40 years), can be a disabling disease if not well and early treated.
Perspectives
It is an opportunity to gather all the drugs used for multiple sclerosis. also to mention the new drugs in clinical trials. The most important is to include this common neurological disease with other well-known diseases in the same book.
Amany Ragab
Cairo University
Read the Original
This page is a summary of: Pharmacotherapy of Multiple Sclerosis and Treatment Strategies, October 2021, Bentham Science Publishers,
DOI: 10.2174/9781681089041121090009.
You can read the full text:
Contributors
The following have contributed to this page
